San Francisco, 24 December 2018: The Report Immunohematology Market Analysis by Product (Immunohematology Analyzer, Immunohematology
Reagent), By End Use (Hospitals, Blood banks, Diagnostic Laboratories), By
Region (North America, Europe, APAC, LATAM & MEA) And Segment Forecasts,
2018 - 2024
According to a report
published by Grand View Research, Inc.; the immunohematology market is anticipated to reach a valuation of
around USD 2.3 billion by 2024. Growing trauma cases can propel the market
during the forecast period (2014 to 2025). Increasing number of hospitals and
trauma care centers to provide emergency care has also increased blood
requirement, thereby driving demand for immunohematology tests and products. Growing
awareness about blood donation and growing number of voluntary donors all over
the world have also led to rise in number of blood banks. This is also expected
to drive the market growth. High prevalence of target diseases including cancer
and sickle cell diseases is also crucial for the market. As patients detected
with these diseases need multiple and recurrent blood transfusion. Products
such as cell counters, reagents, and analyzers help to achieve safe and
efficient transfusion procedure.
Diagnostic laborites and
hospitals are emphasizing more on accepting automated instrumentation and
incorporation of several functions in one platform. This is also expected to
fuel the market growth in the coming years. High involvement of government organizations
and NGOs play an important role in the market. Furthermore, new product
launches and introduction of innovative technologies for blood screening is
expected to drive the market growth. For example, mobile applications can
assist to track the blood donation activity of volunteer donors and encourages
donors to donate regularly by sending notification.
Access Research Report of Immunohematology Market@ www.grandviewresearch.com/industry-analysis/immunohematology-market
Worldwide immunohematology
market can be segmented on the basis of product, end-use, and region. Based on
product, the market can be classified into immunohematology analyzer and
immunohematology reagent. The immunohematology reagents segment was the leading
segment in in 2015. The segment is
mainly driven due to availability of wide product range and high adoption of
these reagents in blood banks. The automated analyzers function on some
specific reagents, thus making it a compulsory and recurring purchase for
hospitals and diagnostic laboratories. In immunohematology analyzers segment,
the automated analyzer is likely to show rapid growth during the forecast
period. They are accurate and provides quick results, and generally uses less reagents.
In addition, some analyzers can show immediate digital results on the screen.
This aids quick screening and categorization of blood.
As per end-use, the market can
be categorized into blood banks, hospitals, and diagnostic laboratories. The
hospitals segment conquered the market in 2015 owing to growing number of
emergency cases due to road accidents and other reasons. Government and private
institutions are spending high in developing and upgrading emergency sections
in hospitals to augment survival chances of patients.
Browse more reports of this category by
Grand View Research at: www.grandviewresearch.com/industry/medical-devices
Hospitals accounted for the
largest share in the end-use segment of immunohematology market. It is
mandatory for hospitals to check donated blood for infections, set parameters
of hematology components, and perform pre-transfusion compatibility tests of
donor and recipients.
Geographically, the market can
be divided into North America; Europe; Asia Pacific; Latin America; and Middle
East and Africa. North America held for the major market share of more than 40%
in 2015. Presence of numerous trauma centers and blood banks are driving the
need for immunohematology products in the region. Need for transfusion is high
in the U.S. Additionally, high adoption of new technologies and automation is
also supporting the regional growth. Frequent products approved by the U.S. FDA
for technologically advanced products is also encouraging companies to
introduce new products in the region. Europe is also considered as one of the
attractive markets for hematology due to presence of prominent players. Asia
Pacific region is likely to grow significantly during the forecast period. Participants
in the market are expanding their facilities in this region to take an
advantage of unexploited opportunities in this region.
Some of the prominent
companies operating in the immunohematology market include Hologic, Inc.;
Bio-Rad Laboratories, Inc.; Beckman Coulter, Inc.; ThermoFisher; and Ortho
Clinical Diagnostics. Growing investments by players in R&D is expected to
fuel the market growth in the coming years.
Access
Press Release of Immunohematology Market@
www.grandviewresearch.com/press-release/global-immunohematology-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment